Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05104567
Title A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sanofi

colorectal cancer

stomach cancer

hepatocellular carcinoma

gastroesophageal junction adenocarcinoma

esophagus squamous cell carcinoma


Cetuximab + THOR-707

Pembrolizumab + THOR-707

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | BEL

No variant requirements are available.